TGFB1 and neoplasm: Tumor resection provides an advantage for immune therapies as it helps to reduce the level of immunosuppressive factors produced and secreted by the tumor cells, such as transforming growth factor-beta (TGF-β) or prostaglandin-E2 [69,70].